Citi Research Reevaluates Bristol-Myers, Lowers Price Target
September 20, 2016 at 09:13 AM EDT
Expectations are for an “underwhelming subgroup analysis” when the CheckMate-026 trial is presented at the forthcoming ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.